CITRUCEL (GlaxoSmithKline Consumer Healthcare Holdings (US) LLC)
Welcome to the PulseAid listing for the CITRUCEL drug offered from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
NON-PROPRIETARY NAME: | methylcellulose |
SUBSTANCE NAME: | METHYLCELLULOSE (4000 MPA.S) |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2010-02-01 |
END MARKETING DATE: | 0000-00-00 |
CITRUCEL HUMAN OTC DRUG Details:
Item Description | CITRUCEL from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
LABELER NAME: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2010-02-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0135-0199_9431402e-f163-4a0f-bb83-ddd06c3f1855 |
PRODUCT NDC: | 0135-0199 |
APPLICATION NUMBER: | part334 |
Other METHYLCELLULOSE (4000 MPA.S) Pharmaceutical Manufacturers / Labelers: